Gå ubegrenset med Magzter GOLD
Få ubegrenset tilgang til over 9000 magasiner, aviser og premiumhistorier for bare
Prøve GULL - Gratis
Uncertainty persists for pharma
Mint New Delhi
|April 11, 2025
US President Donald Trump's latest 90-day pause on tariffs on all nations except China should come as a breather for Indian pharma stocks. The Nifty Pharma index is down about 5% from its close on 2 April.
While pharma was exempted initially, Trump's statements point out that the pharma sector would also face tariffs. The White House 2 April release announcing tariffs mentions pharma as a focus sector.
The delay in imposing tariffs reflects the complex dynamics of the sector, including the risk of drug shortages getting aggravated. "All in all, several outcomes are possible, with near-term uncertainty being a certainty," said Kotak Institutional Equities. For instance, if tariffs are applied at a fixed rate across all the countries, Indian pharma companies could have an edge because of their cost advantage.
Denne historien er fra April 11, 2025-utgaven av Mint New Delhi.
Abonner på Magzter GOLD for å få tilgang til tusenvis av kuraterte premiumhistorier og over 9000 magasiner og aviser.
Allerede abonnent? Logg på
FLERE HISTORIER FRA Mint New Delhi
Mint New Delhi
Sebi now trains sights on commodity derivatives
Following clampdown on equity derivatives after studies revealed steep retail losses, the stock market regulator is turning its attention to the commodity derivatives segment (CDS).
2 mins
November 28, 2025
Mint New Delhi
Refiners, SCI tap Korean giants for local shipyard
Indian Oil, Bharat Petroleum and Hindustan Petroleum are part of the discussions
4 mins
November 28, 2025
Mint New Delhi
360 One, Steadview, others to invest in Wakefit ahead of IPO
A clutch of firms, including 360 One, Steadview Capital, WhiteOak Capital and Info Edge, is expected to invest in home-furnishings brand Wakefit Innovations Ltd just ahead of its initial public offering (IPO) next month, three people familiar with the matter said.
3 mins
November 28, 2025
Mint New Delhi
Would you like to be interviewed by an AI bot instead?
I don't think I want to be interviewed by a human again,\" said a 58-year-old chartered accountant who recently had an interview with a multinational company.
3 mins
November 28, 2025
Mint New Delhi
India, UAE review trade agreement to ease market access
Officials of India and the United Arab Emirates (UAE) met on Thursday to review how the Comprehensive Economic Partnership Agreement (CEPA) is working, and remove frictions that may be impeding trade between the two nations.
1 mins
November 28, 2025
Mint New Delhi
It's a multi-horse Street race now as Smids muscle in
For years, India’s stock market ran on the shoulders of a few giants. Not anymore.
3 mins
November 28, 2025
Mint New Delhi
The curious case of LIC's voting on RIL, Adani resolutions
Life Insurance Corp. of India Ltd, or LIC, consistently approved or never opposed resolutions proposed before shareholders of Reliance Industries Ltd (RIL) or any Adani Group company since 1 April 2022, even as it rejected several similar proposals at other large companies, some even part of other conglomerates, a Mint review of about 9,000 voting decisions by the government-run insurer showed.
8 mins
November 28, 2025
Mint New Delhi
Investors expect AI use to soar. That's not happening
On November 20th American statisticians released the results of a survey. Buried in the data is a trend with implications for trillions of dollars of spending.
4 mins
November 28, 2025
Mint New Delhi
CANADA'S STARTUP VISA: PUTTING LIVES ON HOLD
Legal uncertainty has left entrepreneurs stuck despite building businesses and putting down roots
8 mins
November 28, 2025
Mint New Delhi
Gupta pilfered from fraud, Trafigura says
Commodity trader Trafigura's lawyers accused Indian businessman Prateek Gupta on Thursday of siphoning off funds from an alleged $600 million metals fraud to prop up his struggling business empire.
1 min
November 28, 2025
Listen
Translate
Change font size